Hilden Pharmacy Limited NI049334 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is that of pharmaceutical retailer. Digita Accounts Production Advanced 6.30.9574.0 true true NI049334 2023-03-01 2024-02-29 NI049334 2024-02-29 NI049334 bus:OrdinaryShareClass1 2024-02-29 NI049334 core:CurrentFinancialInstruments 2024-02-29 NI049334 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 NI049334 core:FurnitureFittingsToolsEquipment 2024-02-29 NI049334 core:MotorVehicles 2024-02-29 NI049334 core:OtherPropertyPlantEquipment 2024-02-29 NI049334 bus:SmallEntities 2023-03-01 2024-02-29 NI049334 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 NI049334 bus:FilletedAccounts 2023-03-01 2024-02-29 NI049334 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 NI049334 bus:Director2 2023-03-01 2024-02-29 NI049334 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 NI049334 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 NI049334 core:FurnitureFittings 2023-03-01 2024-02-29 NI049334 core:FurnitureFittingsToolsEquipment 2023-03-01 2024-02-29 NI049334 core:MotorVehicles 2023-03-01 2024-02-29 NI049334 core:OfficeEquipment 2023-03-01 2024-02-29 NI049334 core:OtherPropertyPlantEquipment 2023-03-01 2024-02-29 NI049334 core:PlantMachinery 2023-03-01 2024-02-29 NI049334 countries:NorthernIreland 2023-03-01 2024-02-29 NI049334 2023-02-28 NI049334 core:FurnitureFittingsToolsEquipment 2023-02-28 NI049334 core:MotorVehicles 2023-02-28 NI049334 core:OtherPropertyPlantEquipment 2023-02-28 NI049334 2022-03-01 2023-02-28 NI049334 2023-02-28 NI049334 bus:OrdinaryShareClass1 2023-02-28 NI049334 core:CurrentFinancialInstruments 2023-02-28 NI049334 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 NI049334 core:FurnitureFittingsToolsEquipment 2023-02-28 NI049334 core:MotorVehicles 2023-02-28 NI049334 core:OtherPropertyPlantEquipment 2023-02-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: NI049334

Hilden Pharmacy Limited

Unaudited Filleted Financial Statements

for the Year Ended 29 February 2024

 

Hilden Pharmacy Limited

(Registration number: NI049334)
Balance Sheet as at 29 February 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

4,289

6,588

Current assets

 

Stocks

5

55,150

55,150

Debtors

6

154,034

145,549

Cash at bank and in hand

 

80,881

89,490

 

290,065

290,189

Creditors: Amounts falling due within one year

7

(231,024)

(235,811)

Net current assets

 

59,041

54,378

Net assets

 

63,330

60,966

Capital and reserves

 

Called up share capital

8

100

100

Retained earnings

63,230

60,866

Shareholders' funds

 

63,330

60,966

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

Hilden Pharmacy Limited

(Registration number: NI049334)
Balance Sheet as at 29 February 2024

Approved and authorised by the Board on 29 November 2024 and signed on its behalf by:
 

.........................................
Mr Robert David Finlay
Director

 

Hilden Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in Northern Ireland.

The principal place of business is:
56-58 Grand St, Lisburn , Co. Antrim, BT27 4UD, Northern Ireland

These financial statements were authorised for issue by the Board on 29 November 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts. The Company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the Company’s activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Hilden Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

25% reducing balance

Office equipment

25% straight line

Plant and machinery

25% straight line

Motor vehicles

15% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Short-term debtors and creditors

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Financial assets, including debtors, are reviewed at the reporting date to determine if there is any evidence of potential impairment. Any losses arising from impairment are recognised in the income statement in operating expenses.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method. Where necessary, provision is made for obsolete, slow moving and defective stock.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 13 (2023 - 14).

 

Hilden Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Plant and equipment
£

Total
£

Cost or valuation

At 1 March 2023

38,040

5,900

8,671

52,611

Additions

407

-

-

407

At 29 February 2024

38,447

5,900

8,671

53,018

Depreciation

At 1 March 2023

35,922

3,537

6,564

46,023

Charge for the year

766

885

1,055

2,706

At 29 February 2024

36,688

4,422

7,619

48,729

Carrying amount

At 29 February 2024

1,759

1,478

1,052

4,289

At 28 February 2023

2,118

2,363

2,107

6,588

5

Stocks

2024
£

2023
£

Goods for resale

55,150

55,150

 

Hilden Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

6

Debtors

2024
£

2023
£

Trade debtors

96,067

84,967

Prepayments

1,794

4,189

Other debtors

56,173

56,393

 

154,034

145,549

7

Creditors: amounts falling due within one year

2024
£

2023
£

Trade creditors

173,552

155,278

Taxation and social security

1,294

822

Accruals and deferred income

9,300

9,500

Other creditors

46,878

70,211

231,024

235,811

8

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100